The concentration of antigens in the blood can be determined by using one of the most common in-vitro assay methods: radioimmunoassay (RIA). Competitive binding assay is the foundation of the radioimmunoassay. Radioimmunoassay is used to quantify the amount of antigen bound by an antibody in this method. Because it uses antibodies, this technique is extremely sensitive and can detect extremely low concentrations of hormones and drugs. Clinical laboratory analytes such nucleic acid, hormones, proteins, and medicines all benefit greatly from the use of immunoassays. In order to find new biomarkers for illness diagnosis, more sensitive assays need to be developed. Radioimmunoassay has become increasingly significant in the field of medical diagnostics as a result of its high degree of specificity of results, reliability, sensitivity, and precision. In order to calculate the delivery of radioactivity in free and bound antigens, a separation unit is required for use in radioimmunoassay, together with bound antigen, a radio tagged antigen, and a pure antigen. In the early identification and evaluation of cancer, various chronic diseases, and the diagnosis of neurological disorders, radioimmunoassay techniques are used. Radioimmunoassay is a method used in the pharmaceutical and biotechnology industries for testing medications.
Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1770
Radioimmunoassay Market – Dynamics
It is expected that the radioimmunoassay market will expand rapidly over the coming years as a result of the increased incidence of cancer and other infectious disorders. For instance, cancer caused around 609,640 deaths in the United States in 2018, per a report by the American Cancer Society. The pharmaceutical and biotechnology sectors, as well as contract research organizations and academic institutions, are anticipated to be major end-users of radioimmunoassays, which will fuel the market’s expansion during the forecast period. Market growth for radioimmunoassays is anticipated to be propelled by a number of factors over the forecast period, including the rising need for healthcare automation and high throughput procedures in diagnostic labs and research centres to guarantee customer and patient satisfaction with error-free results.
Growth of the global radioimmunoassay market is anticipated to be stymied by a number of issues, including the high cost of equipment needed for procedures and the presence of dangerous radioactive material in the assay.
Radioimmunoassay Market – Competitive Landscape
DRG international, Inc., DIAsource ImmunoAssays, IBL Internationa, MP Biomedicals, Beckman Coulter, Inc., PerkinElmer, Inc., Dia Dorin S.p.A., Cisbi, EMD Millipore, Berthold Technologies GmbH & Co. KG, Euro Diagnostica, and Izotop are all major competitors in the global radioimmunoassay industry. In order to maintain their market share, the industry’s leading companies are emphasising innovative techniques like collaboration and increased R&D funding. As an illustration, in 2016, the immunoassay products and molecular diagnostics business of Quest Diagnostics were purchased by the Italian company DiaSorin S.p.A for US$300 million.
Radioimmunoassay Market – Taxonomy
Based on the product type, the market for radioimmunoassay worldwide is classified into:
- Kits and Reagents
- Analyzers
Based on the application, the market for radioimmunoassay worldwide is classified into:
- Scientific Research
- Medical Diagnosis
Based on the end user, the market for radioimmunoassay worldwide is classified into:
- Academic Research Institute
- Hospitals
- Contract Research Organizations
- Pharmaceutical and Biotechnology Industry
Based on geography, the market for radioimmunoassay worldwide is divided into:
- North America
- Asia Pacific
- Latin America
- Middle East
- Europe
- Africa
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/1770
Radioimmunoassay Market – Regional Insights
The radioimmunoassay market is broken down into regions such as North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. Because of factors like as increasing product innovation, higher infection rates, stronger healthcare infrastructure, and greater public awareness, North America currently has the largest share of the global market. Also fueling the expansion of the radioimmunoassay business is the government’s encouragement of infection-free states. For instance, 16.8 million visits to doctors’ offices were attributed to infectious and parasitic disorders in 2015. This data comes from the 2015 National Ambulatory Medical Care survey.
Over the projected period, the market is expected to grow at a particularly high rate in Asia and the Pacific because of the region’s huge susceptible population and rising healthcare research efforts. According to a 2011 WHO report, for example, this area carries about 37% of the world’s perinatal conditions, 35% of the world’s nutritional deficiencies, 33% of the world’s maternal conditions, 30% of the world’s respiratory infections, and 27% of the world’s burden of infectious and parasitic diseases.
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Market Overview
- Definition of Radioimmunoassay Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Radioimmunoassay Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/1770
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Explore More Related Insights:
Pregnancy testing devices market
Cervical cancer diagnostic tests market
Physician office diagnostic market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837